Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area.

scientific article published on 24 March 2014

Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area. is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2014PNAS..111E1648M
P356DOI10.1073/PNAS.1315542111
P932PMC publication ID4000785
P698PubMed publication ID24706819
P5875ResearchGate publication ID261409561

P50authorStephanie L. BorglandQ41654211
Theodore M KameneckaQ88039489
P2093author name stringWilliam A Carlezon
Jennifer L Thompson
Paul J Kenny
John W Muschamp
Linda C Hassinger
Sara Onvani
George Voren
Jonathan A Hollander
P2860cites workImpulsivity as a determinant and consequence of drug use: a review of underlying processesQ24630679
Neurocircuitry of addictionQ24647156
A role for brain stress systems in addictionQ24649537
The orexin system regulates alcohol-seeking in ratsQ24671740
Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPRQ24675425
Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivationQ28257589
Neural substrates of awakening probed with optogenetic control of hypocretin neuronsQ29615343
Neurons containing hypocretin (orexin) project to multiple neuronal systemsQ29619641
Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcersQ30491390
Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement.Q33770861
The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuseQ33890721
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistryQ34153836
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behaviorQ34245006
Orexin/hypocretin modulates response of ventral tegmental dopamine neurons to prefrontal activation: diurnal influences.Q34415512
Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine.Q34483780
Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine.Q34494218
Habenular α5 nicotinic receptor subunit signalling controls nicotine intakeQ34816555
Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivityQ35269480
Highly specific role of hypocretin (orexin) neurons: differential activation as a function of diurnal phase, operant reinforcement versus operant avoidance and light levelQ35591448
Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.Q35635672
Insight into the relationship between impulsivity and substance abuse from studies using animal modelsQ36050384
Hypocretin-1 receptors regulate the reinforcing and reward-enhancing effects of cocaine: pharmacological and behavioral genetics evidence.Q36110661
Development of κ opioid receptor antagonistsQ36728154
Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currentsQ36787595
Kinase cascades and ligand-directed signaling at the kappa opioid receptorQ36900733
Dynorphin and the pathophysiology of drug addictionQ36942175
The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation rewardQ36992810
Insular hypocretin transmission regulates nicotine rewardQ37039609
Addiction and the brain antireward systemQ37043564
Orexin signaling mediates the antidepressant-like effect of calorie restrictionQ37269868
Orexin/hypocretin signaling at the orexin 1 receptor regulates cue-elicited cocaine-seekingQ37407124
kappa-Opioid receptor signaling and brain reward functionQ37455456
Role of orexin/hypocretin in dependence and addiction.Q37584411
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviorsQ37589122
Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats.Q40557626
The social defeat animal model of depression shows diminished levels of orexin in mesocortical regions of the dopamine system, and of dynorphin and orexin in the hypothalamusQ42506937
1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptorQ43679857
Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental areaQ43975918
Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins.Q44270164
κ-Opioid Agonists Directly Inhibit Midbrain Dopaminergic NeuronsQ44343360
Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J miceQ44344098
Effects of kappa-opioid receptor ligands on intracranial self-stimulation in ratsQ44344204
Dynorphin Is a Specific Endogenous Ligand of the κ Opioid ReceptorQ44352111
Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminalsQ44905912
A role for lateral hypothalamic orexin neurons in reward seekingQ46650606
A role for hypocretin (orexin) in male sexual behavior.Q48241796
Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides.Q48338808
Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats.Q48387652
Differential expression of orexin receptors 1 and 2 in the rat brainQ48693654
Orexin (hypocretin) neurons contain dynorphin.Q48785521
A novel procedure for pre-embedding double immunogold-silver labeling at the ultrastructural levelQ49023458
The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in ratsQ64218040
A review on electron microscopy and neurotransmitter systemsQ81078577
P4510describes a project that usesImageJQ1659584
P433issue16
P407language of work or nameEnglishQ1860
P921main subjectdynorphinQ324076
P304page(s)E1648-55
P577publication date2014-03-24
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleHypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area
P478volume111

Reverse relations

cites work (P2860)
Q46514264A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
Q36001330Acetylcholine Acts through Nicotinic Receptors to Enhance the Firing Rate of a Subset of Hypocretin Neurons in the Mouse Hypothalamus through Distinct Presynaptic and Postsynaptic Mechanisms(.)
Q35295721Binge-like consumption of ethanol and other salient reinforcers is blocked by orexin-1 receptor inhibition and leads to a reduction of hypothalamic orexin immunoreactivity
Q57184128Cell type- and pathway-specific synaptic regulation of orexin neurocircuitry
Q92649112Chemogenetic Modulation of Orexin Neurons Reverses Changes in Anxiety and Locomotor Activity in the A53T Mouse Model of Parkinson's Disease
Q44345663Chronic nicotine-induced changes in gene expression of delta and kappa-opioid receptors and their endogenous ligands in the mesocorticolimbic system of the rat.
Q38698951Computational implications of biophysical diversity and multiple timescales in neurons and synapses for circuit performance
Q33558914Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress
Q52662325Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.
Q53687526DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants.
Q49646040Differences in trait impulsivity do not bias the response to pharmacological drug challenge in the rat five-choice serial reaction time task.
Q61796757Distinct Subsets of Lateral Hypothalamic Neurotensin Neurons are Activated by Leptin or Dehydration
Q58698159Drug Seeking and Relapse: New Evidence of a Role for Orexin and Dynorphin Co-transmission in the Paraventricular Nucleus of the Thalamus
Q26997989Drug withdrawal conceptualized as a stressor.
Q47312810Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence
Q89956203Dynorphin and its role in alcohol use disorder
Q42485658Dynorphin inhibits basal forebrain cholinergic neurons by pre- and postsynaptic mechanisms
Q55023327Early-life adversity facilitates acquisition of cocaine self-administration and induces persistent anhedonia.
Q47329791Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine
Q58608771Enhanced food-related responses in the ventral medial prefrontal cortex in narcolepsy type 1
Q39358557Functional consequences of neuropeptide and small-molecule co-transmission
Q47118659Global analysis of gene expression mediated by OX1 orexin receptor signaling in a hypothalamic cell line.
Q38950401How contexts promote and prevent relapse to drug seeking.
Q38865497Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour.
Q55442317Hypocretin as a Hub for Arousal and Motivation.
Q47333843Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling
Q41925736Hypocretin receptor 1 knockdown in the ventral tegmental area attenuates mesolimbic dopamine signaling and reduces motivation for cocaine
Q39183160Hypocretin/Orexin and Plastic Adaptations Associated with Drug Abuse
Q35006072Hypocretin/Orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1.
Q52310246Hypocretin/orexin knock-out mice display disrupted behavioral and dopamine responses to cocaine.
Q38687612Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders
Q35956461Hypothalamic neuropeptide signaling in alcohol addiction
Q90307797Identification of discrete, intermingled hypocretin neuronal populations
Q89819781Increased Hypothalamic Projections to the Lateral Hypothalamus and Responses to Leptin in Rat Neonates From High Fat Fed Mothers
Q40284548Individual differences in orexin-I receptor modulation of motivation for the opioid remifentanil
Q38534913Interactions of the histamine and hypocretin systems in CNS disorders.
Q35736840Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment
Q53820719Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats.
Q89713018Learned avoidance requires VTA KOR-mediated reductions in dopamine
Q47880888Modeling cocaine relapse in rodents: Behavioral considerations and circuit mechanisms.
Q89983521Modulation of feeding behavior and metabolism by dynorphin
Q35105241Motivational activation: a unifying hypothesis of orexin/hypocretin function
Q41664909Neurochemical Heterogeneity Among Lateral Hypothalamic Hypocretin/Orexin and Melanin-Concentrating Hormone Neurons Identified Through Single-Cell Gene Expression Analysis
Q38869219Neuroendocrine Regulation of Anxiety: Beyond the Hypothalamic-Pituitary-Adrenal Axis
Q52316238Neuropeptidomics of the Rat Habenular Nuclei.
Q48587669Nicotinic receptor blockade decreases fos immunoreactivity within orexin/hypocretin-expressing neurons of nicotine-exposed rats.
Q36672532Nigrostriatal Dopamine Acting on Globus Pallidus Regulates Sleep.
Q64120996On the Abilities of Unconscious Freudian Motivational Drives to Evoke Conscious Emotions
Q43061528Opioid and hypocretin neuromodulation of ventral tegmental area neuronal subpopulations
Q37725190Opposing roles of cotransmission of dynorphin and hypocretin on reward and motivation.
Q35307482Optogenetic evidence for inhibitory signaling from orexin to MCH neurons via local microcircuits
Q47357997Orexin and Central Modulation of Cardiovascular and Respiratory Function
Q91875136Orexin signaling in GABAergic lateral habenula neurons modulates aggressive behavior in male mice
Q39049017Orexin signaling in rostral lateral hypothalamus and nucleus accumbens shell in the control of spontaneous physical activity in high- and low-activity rats.
Q48217405Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats
Q47671028Orexin/Hypocretin System: Role in Food and Drug Overconsumption
Q47699370Orexin/Hypocretin and Organizing Principles for a Diversity of Wake-Promoting Neurons in the Brain
Q38849902Orexin/hypocretin neuron activation is correlated with alcohol seeking and preference in a topographically specific manner
Q58699595Orexinergic Modulation of Spinal Motor Activity in the Neonatal Mouse Spinal Cord
Q89187439Orexins and stress
Q58605289Parallel circuits from the bed nuclei of stria terminalis to the lateral hypothalamus drive opposing emotional states
Q92479425Presynaptic MAST kinase controls opposing postsynaptic responses to convey stimulus valence in Caenorhabditis elegans
Q44341733Prodynorphin and kappa opioid receptor mRNA expression in the brain relates to social status and behavior in male European starlings
Q36461023Progressive Loss of the Orexin Neurons Reveals Dual Effects on Wakefulness
Q57160068Recent advances in understanding the roles of hypocretin/orexin in arousal, affect, and motivation
Q47647841Regulation of lateral hypothalamic orexin activity by local GABAergic neurons.
Q47658139Restoring Serotonergic Homeostasis in the Lateral Hypothalamus Rescues Sleep Disturbances Induced by Early-Life Obesity.
Q50508409Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats.
Q26770785Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction
Q53481362Stay alert, don't get hurt.
Q38832061Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine
Q47878237The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects.
Q30362407The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems.
Q64104867The Network Mechanism of the Central Circadian Pacemaker of the SCN: Do AVP Neurons Play a More Critical Role Than Expected?
Q47788221The Role of Orexins/Hypocretins in Alcohol Use and Abuse.
Q64054609The Treatment of Narcolepsy With Amphetamine-Based Stimulant Medications: A Call for Better Understanding
Q36309147The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking
Q52316130The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders.
Q37072638The integrative role of orexin/hypocretin neurons in nociceptive perception and analgesic regulation.
Q34650892The kappa opioid receptor: from addiction to depression, and back.
Q90463916The neurobiological basis of narcolepsy
Q38444486The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism
Q90015566The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task
Q58097452The role of co-neurotransmitters in sleep and wake regulation
Q34668388To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance
Q40273091Upregulation of orexin/hypocretin expression in aged rats: Effects on feeding latency and neurotransmission in the insular cortex
Q33364025VTA dopamine neuron plasticity - the unusual suspects
Q26751118Ventral Tegmental Area Afferents and Drug-Dependent Behaviors
Q41811426What optogenetic stimulation is telling us (and failing to tell us) about fast neurotransmitters and neuromodulators in brain circuits for wake-sleep regulation
Q36990567mTOR signalling in the nucleus accumbens shell is critical for augmented effect of TFF3 on behavioural response to cocaine

Search more.